Richard Asher

7.1k total citations · 2 hit papers
61 papers, 5.3k citations indexed

About

Richard Asher is a scholar working on Cell Biology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Richard Asher has authored 61 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cell Biology, 16 papers in Cellular and Molecular Neuroscience and 13 papers in Molecular Biology. Recurrent topics in Richard Asher's work include Proteoglycans and glycosaminoglycans research (20 papers), Nerve injury and regeneration (16 papers) and Glycosylation and Glycoproteins Research (9 papers). Richard Asher is often cited by papers focused on Proteoglycans and glycosaminoglycans research (20 papers), Nerve injury and regeneration (16 papers) and Glycosylation and Glycoproteins Research (9 papers). Richard Asher collaborates with scholars based in United Kingdom, United States and Germany. Richard Asher's co-authors include James W. Fawcett, Daniel A. Morgenstern, A. Bignami, Lawrence Moon, Kate Rhodes, George Perides, Joel M. Levine, Kathryn H. Adcock, John Rogers and Morven C. Shearer and has published in prestigious journals such as The Lancet, JAMA and Journal of Biological Chemistry.

In The Last Decade

Richard Asher

58 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

APRIORITY

1961 1.1k citations Richard Asher profile →
MUNCHAUSEN'S SYNDROME

1951 677 citations Richard Asher profile →

Peers

Countries citing papers authored by Richard Asher

Since Specialization

Citations

This map shows the geographic impact of Richard Asher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Asher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Asher more than expected).

Fields of papers citing papers by Richard Asher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Asher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Asher. The network helps show where Richard Asher may publish in the future.

Co-authorship network of co-authors of Richard Asher

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Asher. A scholar is included among the top collaborators of Richard Asher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Asher. Richard Asher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	‘Once seen, never forgotten’ 2012 ·Clinical and Experimental Dermatology ·Antonia Lloyd-Lavery, (unknown), Richard Asher, (unknown)	2
2	A potential role for bone morphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo 2007 ·European Journal of Neuroscience ·David W. Hampton, Richard Asher, Tôru Kondo, John D. Steeves, Matt S. Ramer, James W. Fawcett	83
3	How does chondroitinase promote functional recovery in the damaged CNS? 2007 ·Experimental Neurology ·Dámaso Crespo, Richard Asher, Rachel Lin, Kate Rhodes, James W. Fawcett	117
4	Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve repair 2007 ·Brain ·Clare Galtrey, Richard Asher, Fatiha Nothias, James W. Fawcett	131
5	Chondroitin 6‐sulphate synthesis is up‐regulated in injured CNS, induced by injury‐related cytokines and enhanced in axon‐growth inhibitory glia 2005 ·European Journal of Neuroscience ·G. Properzi, Daniela Carulli, Richard Asher, Elizabeth M. Muir, Luiz Miguel Camargo, Toin H. Van Kuppevelt, Gerdy B. ten Dam, Yoko Furukawa, (unknown), Kazuyuki Sugahara, Toshihiko Toida, Herbert M. Geller, James W. Fawcett	158
6	Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro 2005 ·Molecular and Cellular Neuroscience ·Richard Asher, Daniel A. Morgenstern, G. Properzi, Akiko Nishiyama, Joel M. Levine, James W. Fawcett	61
7	Expression and glycanation of the NG2 proteoglycan in developing, adult, and damaged peripheral nerve 2003 ·Molecular and Cellular Neuroscience ·Daniel A. Morgenstern, Richard Asher, Murali Naidu, Thomas Carlstedt, Joel M. Levine, James W. Fawcett	59
8	Chapter 22 Chondroitin sulphate proteoglycans in the CNS injury response 2002 ·Progress in brain research ·Daniel A. Morgenstern, Richard Asher, James W. Fawcett	345
9	Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC 2001 ·Nature Neuroscience ·Lawrence Moon, Richard Asher, Kate Rhodes, James W. Fawcett	477
10	On the existence of a cartilage‐like proteoglycan and link proteins in the central nervous system 1995 ·Glia ·Richard Asher, Renate Scheibe, Harold D. Keiser, A. Bignami	90
11	Glial Hyaluronate-Binding Protein Expression in Aggregating Brain Cell Cultures 1993 ·Developmental Neuroscience ·Florianne Monnet‐Tschudi, Marie‐Gabrielle Zurich, Richard Asher, Paul Honegger	7
12	Co-localization of hyaluronic acid and chondroitin sulfate proteoglycan in rat cerebral cortex 1992 ·Brain Research ·A. Bignami, Richard Asher, George Perides	52
13	The extracellular matrix of rat spinal cord: A comparative study on the localization of hyaluronic acid, glial hyaluronate-binding protein, and chondroitin sulfate proteoglycan 1992 ·Experimental Neurology ·A. Bignami, Richard Asher, George Perides	25
14	Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes 1992 ·Experimental Cell Research ·Richard Asher, A. Bignami	69
15	Isolation of a large aggregating proteoglycan from human brain. 1992 ·Journal of Biological Chemistry ·George Perides, Firoz Rahemtulla, W S Lane, Richard Asher, A. Bignami	65
16	Brain Extracellular Matrix and Nerve Regeneration 1991 ·Advances in experimental medicine and biology ·A. Bignami, Richard Asher, George Perides	5
17	Localization of hyaluronate in primary glial cell cultures derived from newborn rat brain1 1991 ·Experimental Cell Research* ·Richard Asher	34
18	Extracellular matrix of central nervous system white matter: Demonstration of an hyaluronate‐protein complex 1991 ·Journal of Neuroscience Research ·Richard Asher, George Perides, Jean‐Jacques Vanderhaeghen, A. Bignami	110
19	Glial hyaluronate-binding protein (GHAP) optic nerve and retina 1990 ·Brain Research ·George Perides, Richard Asher, Doris Dahl, (unknown)	6
20	Straight and Crooked Thinking in Medicine 1954 ·BMJ ·Richard Asher	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact